Alecensa and LidoSite

• Generic Name: alectinib
• Dosage Forms: capsule
• Other Brand Names: Alecensa

Alecensa (alectinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Alecensa is used to treat a certain type of non-small cell lung cancer that has spread to other parts of the body.

Alecensa is used only if your cancer has a specific genetic marker (an abnormal "ALK" gene). Your doctor will test you for this gene.

• Generic Name: epinephrine / lidocaine
• Dosage Forms: Topical Iontophoretic Patch and Controller
• Other Brand Names: D-Care 100X, Lignospan Forte, Lignospan Standard, Xylocaine MPF With Epinephrine, Xylocaine With Epinephrine

LidoSite uses an active transdermal delivery technology known as iontophoresis, which administers medications through the skin via a mild electric current. The LidoSite system administers lidocaine and epinepherine using a patented electrotransport technology that enables the controlled delivery of medication over a predetermined period of time, from minutes to days. Topical anesthetic creams and patches can take up to an hour to numb the skin, while LidoSite works in 10 minutes. LidoSite has successfully completed clinical trials and has been found to significantly decrease pain from needle injections and similar procedures in both adults and children. Lidosite is intended to also address a strong need in adult applications. Its major impact is expected to be in the pediatric population, where pain associated with needlesticks, blood-draw procedures and immunizations is a major issue for the clinician, child and parent.